• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

受体编辑:是福是祸。

Receptor editing for better or for worse.

作者信息

Pelanda Roberta, Torres Raul M

机构信息

Integrated Department of Immunology, National Jewish Medical and Research Center and University of Colorado Health Sciences Center, 1400 Jackson Street, Denver, CO 80206, USA.

出版信息

Curr Opin Immunol. 2006 Apr;18(2):184-90. doi: 10.1016/j.coi.2006.01.005. Epub 2006 Feb 3.

DOI:10.1016/j.coi.2006.01.005
PMID:16460922
Abstract

Receptor editing has emerged from its original identification as a minor secondary mechanism of B cell tolerance to be considered as a dominant mechanism by which autoreactive immature B cells are rendered tolerant. Clonal deletion, previously regarded as the major mechanism of central B cell tolerance, has been shown by recent studies to operate secondarily and only when receptor editing is unable to provide a non-autoreactive specificity. Receptor editing has also been shown to operate during the development of wild-type B lymphocytes, and ongoing investigations demonstrate the influence of particular signaling molecules in the induction and/or inhibition of receptor editing. Together, these studies begin to map the signaling pathways that regulate receptor editing in autoreactive and non-autoreactive immature B cells.

摘要

受体编辑最初被认为是B细胞耐受的一种次要辅助机制,如今已成为使自身反应性未成熟B细胞产生耐受的主要机制。克隆清除曾被视为中枢B细胞耐受的主要机制,但最近的研究表明,它仅在受体编辑无法产生非自身反应性特异性时才作为次要机制发挥作用。研究还表明,受体编辑在野生型B淋巴细胞发育过程中也会发生,并且正在进行的研究揭示了特定信号分子在诱导和/或抑制受体编辑中的作用。这些研究共同勾勒出了调节自身反应性和非自身反应性未成熟B细胞中受体编辑的信号通路。

相似文献

1
Receptor editing for better or for worse.受体编辑:是福是祸。
Curr Opin Immunol. 2006 Apr;18(2):184-90. doi: 10.1016/j.coi.2006.01.005. Epub 2006 Feb 3.
2
Tolerance-induced receptor selection: scope, sensitivity, locus specificity, and relationship to lymphocyte-positive selection.耐受性诱导的受体选择:范围、敏感性、位点特异性以及与淋巴细胞阳性选择的关系。
Immunol Rev. 2004 Feb;197:219-30. doi: 10.1111/j.0105-2896.2004.0106.x.
3
Targeting Anti-Insulin B Cell Receptors Improves Receptor Editing in Type 1 Diabetes-Prone Mice.靶向抗胰岛素B细胞受体可改善1型糖尿病易患小鼠的受体编辑。
J Immunol. 2015 Nov 15;195(10):4730-41. doi: 10.4049/jimmunol.1500438. Epub 2015 Oct 2.
4
B cell deletion, anergy, and receptor editing in "knock in" mice targeted with a germline-encoded or somatically mutated anti-DNA heavy chain.在携带种系编码或体细胞突变抗DNA重链的“敲入”小鼠中的B细胞缺失、失能和受体编辑。
J Immunol. 1998 Nov 1;161(9):4634-45.
5
Receptor editing: genetic reprogramming of autoreactive lymphocytes.受体编辑:自身反应性淋巴细胞的基因重编程。
Cell Biochem Biophys. 1999;31(1):81-8. doi: 10.1007/BF02738156.
6
B cell receptor signaling-based index as a biomarker for the loss of peripheral immune tolerance in autoreactive B cells in rheumatoid arthritis.基于B细胞受体信号传导的指数作为类风湿关节炎中自身反应性B细胞外周免疫耐受丧失的生物标志物。
PLoS One. 2014 Jul 24;9(7):e102128. doi: 10.1371/journal.pone.0102128. eCollection 2014.
7
Receptor editing is the main mechanism of B cell tolerance toward membrane antigens.受体编辑是B细胞对膜抗原产生耐受性的主要机制。
Nat Immunol. 2004 Jun;5(6):645-50. doi: 10.1038/ni1076. Epub 2004 May 23.
8
B cell receptor expression level determines the fate of developing B lymphocytes: receptor editing versus selection.B细胞受体表达水平决定发育中B淋巴细胞的命运:受体编辑与选择。
Proc Natl Acad Sci U S A. 2000 Jun 20;97(13):7435-9. doi: 10.1073/pnas.130182597.
9
Self-antigen does not accelerate immature B cell apoptosis, but stimulates receptor editing as a consequence of developmental arrest.自身抗原不会加速未成熟B细胞凋亡,但会因发育停滞而刺激受体编辑。
Proc Natl Acad Sci U S A. 1997 Aug 19;94(17):9267-72. doi: 10.1073/pnas.94.17.9267.
10
Autoreactivity and the positive selection of B cells.自身反应性与B细胞的阳性选择
Eur J Immunol. 2015 Nov;45(11):2971-7. doi: 10.1002/eji.201444622. Epub 2015 Sep 9.

引用本文的文献

1
Regulation of Foxo1 expression is critical for central B cell tolerance and allelic exclusion.Foxo1 表达的调控对于中枢 B 细胞耐受和等位基因排斥至关重要。
Cell Rep. 2024 Jun 25;43(6):114283. doi: 10.1016/j.celrep.2024.114283. Epub 2024 May 25.
2
Epigenetic Dysregulation in the Pathogenesis of Systemic Lupus Erythematosus.系统性红斑狼疮发病机制中的表观遗传失调。
Int J Mol Sci. 2024 Jan 13;25(2):1019. doi: 10.3390/ijms25021019.
3
B-cell intrinsic and extrinsic signals that regulate central tolerance of mouse and human B cells.
调节小鼠和人 B 细胞中枢耐受的 B 细胞内在和外在信号。
Immunol Rev. 2022 May;307(1):12-26. doi: 10.1111/imr.13062. Epub 2022 Jan 8.
4
The development of human immune system mice and their use to study tolerance and autoimmunity.人类免疫系统小鼠的发展及其在研究耐受性和自身免疫性方面的应用。
J Transl Autoimmun. 2019 Nov 11;2:100021. doi: 10.1016/j.jtauto.2019.100021. eCollection 2019 Dec.
5
TRAF3 Acts as a Checkpoint of B Cell Receptor Signaling to Control Antibody Class Switch Recombination and Anergy.TRAF3 作为 B 细胞受体信号的检查点,控制抗体类别转换重组和无能。
J Immunol. 2020 Aug 1;205(3):830-841. doi: 10.4049/jimmunol.2000322. Epub 2020 Jun 26.
6
Active PI3K abrogates central tolerance in high-avidity autoreactive B cells.活性 PI3K 可消除高亲和力自身反应性 B 细胞中的中枢耐受。
J Exp Med. 2019 May 6;216(5):1135-1153. doi: 10.1084/jem.20181652. Epub 2019 Apr 4.
7
YY1 binds to the E3' enhancer and inhibits the expression of the immunoglobulin κ gene via epigenetic modifications.YY1 通过表观遗传修饰结合到 E3' 增强子上,并抑制免疫球蛋白 κ 基因的表达。
Immunology. 2018 Dec;155(4):491-498. doi: 10.1111/imm.12990. Epub 2018 Aug 29.
8
Activation of the MEK-ERK Pathway Is Necessary but Not Sufficient for Breaking Central B Cell Tolerance.MEK-ERK 通路的激活对于打破中枢 B 细胞耐受是必要的,但不是充分的。
Front Immunol. 2018 Apr 9;9:707. doi: 10.3389/fimmu.2018.00707. eCollection 2018.
9
Phenotyping of autoreactive B cells with labeled nucleosomes in 56R transgenic mice.在 56R 转基因小鼠中用标记核小体对自身反应性 B 细胞进行表型分析。
Sci Rep. 2017 Oct 16;7(1):13232. doi: 10.1038/s41598-017-13422-z.
10
Immunological tolerance as a barrier to protective HIV humoral immunity.免疫耐受作为保护性 HIV 体液免疫的障碍。
Curr Opin Immunol. 2017 Aug;47:26-34. doi: 10.1016/j.coi.2017.06.004. Epub 2017 Jul 17.